CAGR

The government is tackling affordability and productivity with a new grocery benefit and support for Alberta businesses. A look at the strategy's impact.

A new executive hire at a cultural heritage firm signals a major shift. Can the architects of growth and the guardians of the past build the future together?

Australian biotech Gelteq is opening a China R&D hub to chase explosive growth, but its bold move into a $60B market comes with significant geopolitical risks.

Teva's new Eylea biosimilar hits Europe, a key move in its 'Pivot to Growth' strategy that promises to shake up the lucrative ophthalmology market.

Manhattan Associates' partner awards reveal a critical truth: the future of AI logistics isn't just about code, but a complex symbiosis of tech and human expertise.

The renewed pact between PENTAX Medical and FUJIFILM promises over a decade of support for their EUS systems, a strategic move in a booming med-tech market.

With its first product launch, Daré Bioscience enters a new commercial era. But can a single probiotic launch secure the future of its ambitious pipeline?

A Florida biotech is using a novel gene therapy to correct aging-related errors. But the real story is its funding: a decentralized, crypto-style model.

As AI tools offer students instant answers, EdTech firm Thea has served a billion questions instead. We investigate its 'Socratic' model and its ambitious bid to rewire learning.

Fairplay's new user verification signals a market-wide shift. As India's stringent new rules take hold, compliance is becoming a key strategic asset.

RFMW expands its deal with Innovative Power Products to a global scale, a strategic shift poised to reshape the high-frequency component market.

AM Best affirms Fairfax's 'Excellent' rating after a year of record profits and major catastrophes. We deconstruct the strategy behind this financial paradox.

As Arizona builds the infrastructure for AI and clean energy, a specialized private fire service is emerging to handle unprecedented risks, securing billions in investment.

APsystems' new AI-driven solar storage solutions, including a plug-and-play balcony unit, aim to move home energy from passive generation to active profit.

A new partnership integrates chip design and system simulation, tackling a key bottleneck in developing the high-speed optical hardware needed for AI.

Parnell's new Sevoflurane offering is more than a product line extension; it's a strategic move to become a one-stop-shop for veterinary anesthesia.

Payroc's alliance with NewtekOne moves beyond payments, embedding a full financial toolkit into its vast merchant network. This signals a major shift in SMB banking.

MIT's Kristin Forbes argues rigid models are failing. She's adapting Sun Tzu's 'Art of War' to help central banks fight today's lightning-fast crises.

The men's supplement industry is shifting from pure performance to holistic vitality. A new launch reveals the economic and scientific forces driving this change.

While others debate AI's future, CEO Eric Vaughan brings a radical playbook of M&A and cultural overhaul to the main stage, proving enterprise AI is here.